SP1 and type 1 diabetes mellitus: In both cultured podocytes and the STZ-induced type 1 diabetes mouse model with hyperglycemia as the major pathologic factor, we demonstrated activation of SP1 transcription activity and subsequent increased expression of the hyperglycemia-responsive dynein subunits.